Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

106
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
106
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

58
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
58
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

369
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
369
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

128
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
128
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

130
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
130
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

223
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
223

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Practice Guideline for Diagnosis and Management of Faltering Weight.

Pediatrics·2026
Same author

Maralixibat for the treatment of severe xanthomas in two children with Alagille syndrome: Case reports.

JPGN reports·2026
Same author

Improving Vaccinations in the Pediatric Transplant Population: 4-Year Quality Improvement Outcomes.

Pediatric transplantation·2026
Same author

Severe cholestasis in neonatal extracorporeal membrane oxygenation.

The journal of extra-corporeal technology·2025
Same author

Condition-Specific Growth Charts for Children With Alagille Syndrome.

JAMA network open·2025
Same author

Elevated Serum Bile Acids Predict Poor Liver Outcomes in Children With Alagille Syndrome: Results From the GALA Study Group.

Liver international : official journal of the International Association for the Study of the Liver·2025

Related Experiment Video

Updated: Sep 28, 2025

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

10.3K

Pediatric Acute Liver Failure.

Catherine Larson-Nath1, Bernadette Vitola2

  • 1Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, University of Minnesota, 2450 Riverside Avenue, Minneapolis, MN 55454, USA.

Critical Care Clinics
|April 4, 2022
PubMed
Summary

Pediatric acute liver failure (PALF) is a rare condition with diverse causes, often unidentified. Early intervention and supportive care are crucial for survival, though transplantation may be necessary for some children.

Keywords:
Acute liver failurePediatricTransplant

More Related Videos

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube

Published on: April 28, 2020

11.5K
A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
09:12

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

2.7K

Related Experiment Videos

Last Updated: Sep 28, 2025

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

10.3K
Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube

Published on: April 28, 2020

11.5K
A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
09:12

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

2.7K

Area of Science:

  • Pediatric Hepatology
  • Critical Care Medicine
  • Genetics and Metabolism

Background:

  • Pediatric acute liver failure (PALF) is a rare but life-threatening condition.
  • It arises from various etiologies, including toxins, infections, metabolic disorders, and immune-mediated diseases.
  • In up to 50% of cases, the underlying cause of PALF remains elusive.

Purpose of the Study:

  • To summarize the critical aspects of pediatric acute liver failure.
  • To highlight the importance of early diagnosis and management strategies.
  • To underscore the current survival rates and the role of liver transplantation.

Main Methods:

  • This is a summary of existing knowledge and clinical practice regarding pediatric acute liver failure.
  • It synthesizes information on causes, diagnosis, and treatment modalities.
  • No new experimental data were generated; it is a review of the current state of the field.

Main Results:

  • Causes of PALF are multifactorial, encompassing toxins, infections, metabolic/genetic disorders, and autoimmune conditions.
  • A significant proportion of PALF cases lack an identifiable etiology.
  • Survival rates without liver transplantation are approximately 50%, emphasizing the need for effective therapies.

Conclusions:

  • Prompt identification, supportive care, and targeted treatments are vital for improving outcomes in pediatric acute liver failure.
  • While liver transplantation is a life-saving option for some, many children can recover with appropriate medical management.
  • Further advancements in the care of children with PALF are needed to enhance survival and reduce long-term morbidity.